MONTREAL, March 25 /CNW Telbec/ - Akela Pharma Inc. (TSX: “AKL”), a drug development company focused on developing therapies for the inhalation and pain markets, today announced that it will report financial results for the fourth quarter and fiscal 2007 ended December 31, 2007 on Monday March 31, 2008.
